PT Kalbe Farma TbkFRA:LCLA -3.33%76 Days Inventory is 109.25 as of Mar. 2026, which is 6% below its 10-year median of 115.96. GuruFocus rates FRA:LCLA with a GF Score™ of 76/100 and a GF Value™ of €0.07 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 918 Drug Manufacturers companies, PT Kalbe Farma Tbk ranks better than 72.88% on this metric.
The historical rank and industry rank for PT Kalbe Farma Tbk's Days Inventory or its related term are showing as below:
FRA:LCLA'
s Days Inventory Range Over the Past 10 Years
Min: 102.55 Med: 115.96 Max: 134.05
Current: 114.2
During the past 13 years, PT Kalbe Farma Tbk's highest Days Inventory was 134.05. The lowest was 102.55. And the median was 115.96.
FRA:LCLA's Days Inventory is ranked better than 72.88% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs FRA:LCLA: 114.20
PT Kalbe Farma Tbk's Days Inventory
declined
from Mar. 2025 (117.68) to Mar. 2026 (109.25).
Inventory Turnover measures how fast the company turns over its inventory within a year.
PT Kalbe Farma Tbk's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.84.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PT Kalbe Farma Tbk's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.74.
PT Kalbe Farma Tbk (FRA:LCLA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
PT Kalbe Farma Tbk's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PT Kalbe Farma Tbk's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
PT Kalbe Farma Tbk Days Inventory Related Terms
PT Kalbe Farma Tbk Days Inventory Historical Data
* Premium members only.
The historical data trend for PT Kalbe Farma Tbk's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:LCLA vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Kalbe Farma Tbk Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's Days Inventory distribution charts can be found below:
* The bar in red indicates where PT Kalbe Farma Tbk's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kalbe Farma Tbk (FRA:LCLA) has a Days Inventory of 109.25 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PT Kalbe Farma Tbk and its competitors. This is near median its historical median of 115.96. Over the past decade, PT Kalbe Farma Tbk's Days Inventory has ranged from 102.55 to 134.05. According to the industry distribution chart, PT Kalbe Farma Tbk ranks #249 out of 918 companies in the Drug Manufacturers industry, placing it in the top 27.1%.
Is PT Kalbe Farma Tbk's Days Inventory too high?
PT Kalbe Farma Tbk's current Days Inventory of 109.25 is near median its 10-year median of 115.96. Over the past 10 years, this metric has ranged from a low of 102.55 to a high of 134.05. The Drug Manufacturers industry median Days Inventory is 164.43. PT Kalbe Farma Tbk's value of 109.25 is 33.6% below this industry median. Based on the distribution chart, PT Kalbe Farma Tbk ranks #249 out of 918 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, PT Kalbe Farma Tbk has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kalbe Farma Tbk's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, PT Kalbe Farma Tbk ranks #249 out of 918 companies for Days Inventory. This puts PT Kalbe Farma Tbk in the upper half of its industry. The industry median Days Inventory is 164.43. PT Kalbe Farma Tbk's value of 109.25 is 33.6% below this benchmark. Historically, PT Kalbe Farma Tbk's own Days Inventory has ranged from 102.55 to 134.05 over the past decade. While the company's 10-year median is 115.96 vs. the industry median of 164.43, PT Kalbe Farma Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Kalbe Farma Tbk's current Days Inventory of 109.25 is 33.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PT Kalbe Farma Tbk and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Kalbe Farma Tbk's current Days Inventory is 109.25, which is near median its own 10-year median of 115.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kalbe Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kalbe Farma Tbk (FRA:LCLA) is currently considered Significantly Undervalued. The stock's GF Value™ is €0.07, compared to a current price of €0.03 — trading 58.6% below its estimated fair value. The current Days Inventory is 109.25, which is near median its 10-year median of 115.96 and 33.6% below the Drug Manufacturers industry median of 164.43. PT Kalbe Farma Tbk's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For PT Kalbe Farma Tbk (FRA:LCLA), the current Days Inventory is 109.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Kalbe Farma Tbk (FRA:LCLA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Kalbe Farma Tbk stock appears to be undervalued.
The current stock price of €0.03 is trading 58.6% below its estimated GF Value™ of €0.07.
GuruFocus considers PT Kalbe Farma Tbk to be Significantly Undervalued.
Key valuation signals for FRA:LCLA:
Days Inventory: 109.25 (near median its 10-year median of 115.96)
GF Value™: €0.07 vs. price of €0.03 (58.6% below fair value)
Industry Position: 33.6% below the Drug Manufacturers median (#249 of 918)
No single metric tells the full story. See the FRA:LCLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Kalbe Farma Tbk is engaged in the development, manufacturing, and trading of pharmaceutical products, including human medicines and consumer health products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. The majority of the company's revenue is derived from the distribution and logistics segments. Its Product and Services are Prescription /Ethicals, Consumer Health, Nutritionals, Distribution & Logistics, Health Services, Medical Devices, and Others.
76GF Score
Get the complete analysis for FRA:LCLA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LCLA has been successfully added to your 
